Clinical, Pathologic, and Immunohistochemical Prognostic Factors in Dogs with Thyroid Carcinoma

被引:51
作者
Campos, M. [1 ]
Ducatelle, R. [2 ]
Rutteman, G. [5 ]
Kooistra, H. S. [5 ]
Duchateau, L. [3 ]
de Rooster, H. [1 ]
Peremans, K. [4 ]
Daminet, S. [1 ]
机构
[1] Univ Ghent, Dept Med & Clin Biol Small Anim, Fac Vet Med, Merelbeke, Belgium
[2] Univ Ghent, Dept Pathol Bacteriol & Poultry Dis, Fac Vet Med, Merelbeke, Belgium
[3] Univ Ghent, Dept Comparat Physiol & Biometr, Fac Vet Med, Merelbeke, Belgium
[4] Univ Ghent, Dept Med Imaging Domest Anim & Orthoped Small Ani, Fac Vet Med, Merelbeke, Belgium
[5] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands
关键词
Calcitonin; E-cadherin; Follicular; Ki-67; Medullary; FOLLICULAR CARCINOMA; KI67; INDEX; CANINE; TUMORS; EXPRESSION; CANCER; THERAPY; KI-67; P27(KIP1); VARIABLES;
D O I
10.1111/jvim.12436
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
BackgroundPrognostic markers for dogs with thyroid tumors are limited. Hypothesis/ObjectivesTo identify clinical, pathologic, and immunohistochemical prognostic factors for dogs with thyroid tumors. AnimalsSeventy dogs with thyroid neoplasia. MethodsRetrospective study. Dogs with thyroid neoplasia were included when follow-up information and formalin-fixed paraffin-embedded tumor samples were available. Immunohistochemistry (IHC) was performed for thyroglobulin, calcitonin, Ki-67, and E-cadherin. Correlation of tumor variables (diameter, volume, localization, scintigraphic uptake, thyroid function, IHC) with local invasiveness and metastatic disease was performed on all tumor samples. Forty-four dogs treated by thyroidectomy were included in a survival analysis. ResultsFifty dogs (71%) had differentiated follicular cell thyroid carcinoma (dFTC) and 20 (29%) had medullary thyroid carcinoma (MTC). At diagnosis, tumor diameter (P=.007; P=.038), tumor volume (P=.020), tumor fixation (P=.002), ectopic location (P=.002), follicular cell origin (P=.044), and Ki-67 (P=.038) were positively associated with local invasiveness; tumor diameter (P=.002), tumor volume (P=.023), and bilateral location (P=.012) were positively associated with presence of distant metastases. Forty-four dogs (28 dFTC, 16 MTC; stage I-III) underwent thyroidectomy. Outcome was comparable between dogs with dFTC and MTC. Macroscopic (P=.007) and histologic (P=.046) vascular invasion were independent negative predictors for disease-free survival. Although time to presentation, histologic vascular invasion and Ki-67 were negatively associated with time to metastases, and time to presentation was negatively associated with time to recurrence, no independent predictors were found. E-cadherin expression was not associated with outcome. Conclusions and Clinical ImportancePrognostic factors have been identified that provide relevant information for owners and clinicians.
引用
收藏
页码:1805 / 1813
页数:9
相关论文
共 37 条
[1]   FOLLICULAR THYROID-CANCER TREATED AT THE MAYO-CLINIC, 1946 THROUGH 1970 - INITIAL MANIFESTATIONS, PATHOLOGICAL FINDINGS, THERAPY, AND OUTCOME [J].
BRENNAN, MD ;
BERGSTRALH, EJ ;
VANHEERDEN, JA ;
MCCONAHEY, WM .
MAYO CLINIC PROCEEDINGS, 1991, 66 (01) :11-22
[2]   Immunohistochemical Expression of Potential Therapeutic Targets in Canine Thyroid Carcinoma [J].
Campos, M. ;
Ducatelle, R. ;
Kooistra, H. S. ;
Rutteman, G. ;
Duchateau, L. ;
Polis, I. ;
Daminet, S. .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 2014, 28 (02) :564-570
[3]   A COMPARISON OF MEDULLARY-THYROID CARCINOMA AND THYROID ADENOCARCINOMA IN DOGS - A RETROSPECTIVE STUDY OF 38 CASES [J].
CARVER, JR ;
KAPATKIN, A ;
PATNAIK, AK .
VETERINARY SURGERY, 1995, 24 (04) :315-319
[4]  
Erickson LA, 1998, MODERN PATHOL, V11, P169
[5]  
Gilliland FD, 1997, CANCER-AM CANCER SOC, V79, P564, DOI 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO
[6]  
2-0
[7]  
HARARI J, 1986, J AM VET MED ASSOC, V188, P1160
[8]  
Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO
[9]  
2-1
[10]   Outcomes of patients with differentiated thyroid carcinoma following initial therapy [J].
Jonklaas, Jacqueline ;
Sarlis, Nicholas J. ;
Litofsky, Danielle ;
Ain, Kenneth B. ;
Bigos, S. Thomas ;
Brierley, James D. ;
Cooper, David S. ;
Haugen, Bryan R. ;
Ladenson, Paul W. ;
Magner, James ;
Robbins, Jacob ;
Ross, Douglas S. ;
Skarulis, Monica ;
Maxon, Harry R. ;
Sherman, Steven I. .
THYROID, 2006, 16 (12) :1229-1242